/
Stock
/
/
APIChangelogInfoCareers

BIOGEN

Trade BIIB
BIIB Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '2508016024032040048002k4k6k8k10k12k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-07-08
2025-07-16
IZZAR RACHID
Head of Global Product Strat.
S - Sale
Common Stock
-2,223
$135.00
-300K
1
$20.42B
2025-06-17
2025-06-18
ROWINSKY ERIC
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
FREIRE MARIA
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
LANGER SUSAN
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
MANTAS JESUS
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
MINOR LLOYD
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
PANGALOS MENELAS
A - Grant
Restricted Stock Unit
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
PATOLAWALA MONISH
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
SHERWIN STEPHEN
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
HAWKINS WILLIAM
A - Grant
Common Stock
2,370
$0.00
1
$20.42B
2025-06-17
2025-06-18
DORSA CAROLINE
A - Grant
Common Stock
3,160
$0.00
1
$20.42B
2025-05-19
2025-05-20
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-3,806
$126.00
-480K
1
$20.42B
2025-05-02
2025-05-05
DORSA CAROLINE
P - Purchase
Common Stock
1,235
$123.00
152K
1
$20.42B
2025-05-01
2025-05-05
KEENEY ADAM
Head of Corporate Development
M - Exercise
Common Stock
938
$0.00
1
$20.42B
2025-05-01
2025-05-05
KEENEY ADAM
Head of Corporate Development
M - Exercise
Restricted Stock Unit
-938
$0.00
1
$20.42B
2025-05-01
2025-05-05
KEENEY ADAM
Head of Corporate Development
F - Tax
Common Stock
-454
$121.00
-54,934
1
$20.42B
2025-04-01
2025-04-03
GODBOUT SEAN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
545
$0.00
1
$20.42B
2025-03-07
2025-03-10
SHERWIN STEPHEN
S - Sale
Common Stock
-8,760
$150.00
-1.31M
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-445
$143.00
-63,635
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-245
$143.00
-35,035
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,371
$143.00
-196K
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-670
$143.00
-95,810
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-357
$143.00
-51,051
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
2,575
$0.00
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-2,159
$0.00
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
2,159
$0.00
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-1,515
$0.00
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
1,515
$0.00
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-834
$0.00
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
834
$0.00
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-3,257
$0.00
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
3,257
$0.00
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
2,272
$0.00
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,212
$0.00
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,212
$0.00
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-807
$143.00
-115K
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-634
$143.00
-90,662
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-445
$143.00
-63,635
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-245
$143.00
-35,035
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,371
$143.00
-196K
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
2,575
$0.00
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-2,575
$0.00
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-2,272
$0.00
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-670
$143.00
-95,810
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-357
$143.00
-51,051
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-2,575
$0.00
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-2,159
$0.00
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
2,159
$0.00
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-1,515
$0.00
1
$20.42B
2025-02-10
2025-02-12
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
1,515
$0.00
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-834
$0.00
1
$20.42B
2025-02-10
2025-02-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
834
$0.00
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-3,257
$0.00
1
$20.42B
2025-02-10
2025-02-12
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
3,257
$0.00
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-2,272
$0.00
1
$20.42B
2025-02-10
2025-02-12
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
2,272
$0.00
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,212
$0.00
1
$20.42B
2025-02-10
2025-02-12
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,212
$0.00
1
$20.42B
2025-02-10
2025-02-12
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-807
$143.00
-115K
1
$20.42B
2025-02-10
2025-02-12
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-634
$143.00
-90,662
1
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
3,844
$0.00
2
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-1,165
$141.00
-164K
2
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-3,844
$0.00
2
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
3,844
$0.00
2
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-1,165
$141.00
-164K
2
$20.42B
2025-02-07
2025-02-11
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-3,844
$0.00
2
$20.42B
2025-02-07
2025-02-10
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
1,491
$0.00
2
$20.42B
2025-02-07
2025-02-10
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-1,234
$141.00
-174K
2
$20.42B
2025-02-07
2025-02-10
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-1,040
$141.00
-147K
2
$20.42B
2025-02-07
2025-02-10
GROGAN JANE
Head of Research
F - Tax
Common Stock
-443
$141.00
-62,463
1
$20.42B
2025-02-07
2025-02-10
KEENEY ADAM
Head of Corporate Development
F - Tax
Common Stock
-563
$141.00
-79,383
1
$20.42B
2025-02-07
2025-02-10
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-476
$141.00
-67,116
2
$20.42B
2025-02-07
2025-02-10
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,502
$141.00
-212K
2
$20.42B
2025-02-07
2025-02-10
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-1,223
$141.00
-172K
2
$20.42B
2025-02-07
2025-02-10
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-681
$141.00
-96,021
1
$20.42B
2025-02-07
2025-02-10
VIEHBACHER CHRISTOPHER
President and CEO
F - Tax
Common Stock
-3,201
$141.00
-451K
1
$20.42B
2025-02-07
2025-02-10
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-4,130
$0.00
2
$20.42B
2025-02-07
2025-02-10
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
4,130
$0.00
2
$20.42B
2025-02-07
2025-02-10
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-3,436
$0.00
2
$20.42B
2025-02-07
2025-02-10
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
3,436
$0.00
2
$20.42B
2025-02-07
2025-02-10
GROGAN JANE
Head of Research
M - Exercise
Restricted Stock Unit
-1,385
$0.00
1
$20.42B
2025-02-07
2025-02-10
GROGAN JANE
Head of Research
M - Exercise
Common Stock
1,385
$0.00
1
$20.42B
2025-02-07
2025-02-10
KEENEY ADAM
Head of Corporate Development
M - Exercise
Restricted Stock Unit
-1,801
$0.00
1
$20.42B
2025-02-07
2025-02-10
KEENEY ADAM
Head of Corporate Development
M - Exercise
Common Stock
1,801
$0.00
1
$20.42B
2025-02-07
2025-02-10
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-1,491
$0.00
2
$20.42B
2025-02-07
2025-02-10
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-4,551
$0.00
2
$20.42B
2025-02-07
2025-02-10
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
4,551
$0.00
2
$20.42B
2025-02-07
2025-02-10
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-4,042
$0.00
2
$20.42B
2025-02-07
2025-02-10
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
4,042
$0.00
2
$20.42B
2025-02-07
2025-02-10
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-2,216
$0.00
1
$20.42B
2025-02-07
2025-02-10
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
2,216
$0.00
1
$20.42B
2025-02-07
2025-02-10
VIEHBACHER CHRISTOPHER
President and CEO
M - Exercise
Restricted Stock Unit
-9,008
$0.00
1
$20.42B
2025-02-07
2025-02-10
VIEHBACHER CHRISTOPHER
President and CEO
M - Exercise
Common Stock
9,008
$0.00
1
$20.42B
2025-02-06
2025-02-10
VIEHBACHER CHRISTOPHER
President and CEO
A - Grant
Restricted Stock Unit
46,360
$0.00
1
$20.42B
2025-02-06
2025-02-10
SINGHAL PRIYA
Head of Development
A - Grant
Restricted Stock Unit
14,050
$0.00
1
$20.42B
2025-02-06
2025-02-10
ALEXANDER SUSAN
EVP Chief Legal Officer
A - Grant
Restricted Stock Unit
14,750
$0.00
1
$20.42B
2025-02-06
2025-02-10
GREGORY GINGER
EVP, Human Resources
A - Grant
Restricted Stock Unit
11,240
$0.00
1
$20.42B
2025-02-06
2025-02-10
GROGAN JANE
Head of Research
A - Grant
Restricted Stock Unit
5,620
$0.00
1
$20.42B
2025-02-06
2025-02-10
IZZAR RACHID
Head of Global Product Strat.
A - Grant
Restricted Stock Unit
9,130
$0.00
1
$20.42B
2025-02-06
2025-02-10
KEENEY ADAM
Head of Corporate Development
A - Grant
Restricted Stock Unit
9,835
$0.00
1
$20.42B
2025-02-06
2025-02-10
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
10,535
$0.00
1
$20.42B
2025-02-06
2025-02-10
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Restricted Stock Unit
14,050
$0.00
1
$20.42B
2025-01-31
2025-02-03
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-578
$144.00
-83,232
1
$20.42B
2025-01-31
2025-02-03
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,828
$0.00
1
$20.42B
2025-01-31
2025-02-03
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,828
$0.00
1
$20.42B
2024-12-09
2024-12-09
SINGHAL PRIYA
Head of Development
S - Sale
-110
$157.00
-17,270
1
$20.42B
2024-12-06
2024-12-09
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-206
$158.00
-32,548
1
$20.42B
2024-12-06
2024-12-09
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-170
$158.00
-26,860
1
$20.42B
2024-12-06
2024-12-09
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
351
$0.00
1
$20.42B
2024-12-06
2024-12-09
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-426
$0.00
1
$20.42B
2024-12-06
2024-12-09
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
426
$0.00
1
$20.42B
2024-12-06
2024-12-09
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-351
$0.00
1
$20.42B
2024-11-05
2024-11-07
ALEXANDER SUSAN
EVP Chief Legal Officer
G - Gift
Common Stock
20,082
$0.00
1
$20.42B
2024-11-05
2024-11-07
ALEXANDER SUSAN
EVP Chief Legal Officer
G - Gift
Common Stock
-20,082
$0.00
1
$20.42B
2024-11-01
2024-11-04
GROGAN JANE
Head of Research
F - Tax
Common Stock
-204
$174.00
-35,496
1
$20.42B
2024-11-01
2024-11-04
GROGAN JANE
Head of Research
M - Exercise
Restricted Stock Unit
-695
$0.00
1
$20.42B
2024-11-01
2024-11-04
GROGAN JANE
Head of Research
M - Exercise
Common Stock
695
$0.00
1
$20.42B
2024-09-03
2024-09-05
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-431
$204.00
-87,924
1
$20.42B
2024-08-30
2024-09-05
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,668
$0.00
1
$20.42B
2024-08-30
2024-09-05
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-807
$205.00
-165K
1
$20.42B
2024-08-30
2024-09-05
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,668
$0.00
1
$20.42B
2024-06-21
2024-06-25
LANGER SUSAN
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
MANTAS JESUS
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
PATOLAWALA MONISH
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
SHERWIN STEPHEN
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
ROWINSKY ERIC
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
DORSA CAROLINE
A - Grant
Common Stock
1,785
$0.00
1
$20.42B
2024-06-21
2024-06-25
FREIRE MARIA
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-06-21
2024-06-25
HAWKINS WILLIAM
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2024-05-01
2024-05-03
KEENEY ADAM
Head of Corporate Development
M - Exercise
Common Stock
938
$0.00
1
$20.42B
2024-05-01
2024-05-03
KEENEY ADAM
Head of Corporate Development
F - Tax
Common Stock
-276
$216.00
-59,616
1
$20.42B
2024-05-01
2024-05-03
KEENEY ADAM
Head of Corporate Development
M - Exercise
Restricted Stock Unit
-938
$0.00
1
$20.42B
2024-04-02
2024-04-03
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-93
$213.00
-19,809
1
$20.42B
2024-04-01
2024-04-03
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-117
$215.00
-25,155
1
$20.42B
2024-04-01
2024-04-03
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-240
$0.00
1
$20.42B
2024-04-01
2024-04-03
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
240
$0.00
1
$20.42B
2024-02-22
2024-02-26
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-262
$221.00
-57,902
1
$20.42B
2024-02-21
2024-02-21
SINGHAL PRIYA
Head of Development
S - Sale
-108
$221.00
-23,868
1
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
J - Other
Restricted Stock Unit
-485
$0.00
1
$20.42B
2024-02-16
2024-02-21
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Performance Stock Unit
-856
$0.00
1
$20.42B
2024-02-16
2024-02-21
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-404
$0.00
1
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-108
$221.00
-23,868
1
$20.42B
2024-02-16
2024-02-21
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-2,437
$219.00
-534K
2
$20.42B
2024-02-16
2024-02-21
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-2,264
$219.00
-496K
2
$20.42B
2024-02-16
2024-02-21
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-952
$219.00
-208K
2
$20.42B
2024-02-16
2024-02-21
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-396
$219.00
-86,724
2
$20.42B
2024-02-16
2024-02-21
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-3,438
$219.00
-753K
2
$20.42B
2024-02-16
2024-02-21
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-610
$219.00
-134K
2
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-468
$219.00
-102K
2
$20.42B
2024-02-16
2024-02-21
ALEXANDER SUSAN
EVP Chief Legal Officer
J - Other
Restricted Stock Unit
-2,012
$0.00
1
$20.42B
2024-02-16
2024-02-21
GREGORY GINGER
EVP, Human Resources
J - Other
Restricted Stock Unit
-1,879
$0.00
1
$20.42B
2024-02-16
2024-02-21
IZZAR RACHID
Head of Global Product Strat.
J - Other
Restricted Stock Unit
-807
$0.00
1
$20.42B
2024-02-16
2024-02-21
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-537
$0.00
1
$20.42B
2024-02-16
2024-02-21
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-2,684
$0.00
1
$20.42B
2024-02-16
2024-02-21
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-504
$0.00
1
$20.42B
2024-02-16
2024-02-21
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Performance Stock Unit
-3,423
$0.00
1
$20.42B
2024-02-16
2024-02-21
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-1,614
$0.00
1
$20.42B
2024-02-16
2024-02-21
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
5,037
$0.00
2
$20.42B
2024-02-16
2024-02-21
GREGORY GINGER
EVP, Human Resources
M - Exercise
Performance Stock Unit
-3,197
$0.00
1
$20.42B
2024-02-16
2024-02-21
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-1,507
$0.00
1
$20.42B
2024-02-16
2024-02-21
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
4,704
$0.00
2
$20.42B
2024-02-16
2024-02-21
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Performance Stock Unit
-1,370
$0.00
1
$20.42B
2024-02-16
2024-02-21
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-647
$0.00
1
$20.42B
2024-02-16
2024-02-21
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
2,017
$0.00
2
$20.42B
2024-02-16
2024-02-21
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Performance Stock Unit
-914
$0.00
1
$20.42B
2024-02-16
2024-02-21
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-431
$0.00
1
$20.42B
2024-02-16
2024-02-21
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
1,345
$0.00
2
$20.42B
2024-02-16
2024-02-21
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Performance Stock Unit
-4,568
$0.00
1
$20.42B
2024-02-16
2024-02-21
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-2,152
$0.00
1
$20.42B
2024-02-16
2024-02-21
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
6,720
$0.00
2
$20.42B
2024-02-16
2024-02-21
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
1,260
$0.00
2
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
M - Exercise
Performance Stock Unit
-819
$0.00
1
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-389
$0.00
1
$20.42B
2024-02-16
2024-02-21
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,208
$0.00
2
$20.42B
2024-02-15
2024-02-20
ROWINSKY ERIC
P - Purchase
Common Stock
455
$223.00
101K
1
$20.42B
2024-02-12
2024-02-13
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-419
$239.00
-100K
1
$20.42B
2024-02-09
2024-02-13
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-245
$241.00
-59,045
1
$20.42B
2024-02-09
2024-02-13
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,431
$241.00
-345K
1
$20.42B
2024-02-09
2024-02-13
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-761
$241.00
-183K
1
$20.42B
2024-02-09
2024-02-13
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-374
$241.00
-90,134
1
$20.42B
2024-02-09
2024-02-13
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-634
$241.00
-153K
1
$20.42B
2024-02-09
2024-02-13
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-2,575
$0.00
1
$20.42B
2024-02-09
2024-02-13
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
2,575
$0.00
1
$20.42B
2024-02-09
2024-02-13
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-2,158
$0.00
1
$20.42B
2024-02-09
2024-02-13
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
2,158
$0.00
1
$20.42B
2024-02-09
2024-02-13
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-1,515
$0.00
1
$20.42B
2024-02-09
2024-02-13
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
1,515
$0.00
1
$20.42B
2024-02-09
2024-02-13
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-833
$0.00
1
$20.42B
2024-02-09
2024-02-13
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
833
$0.00
1
$20.42B
2024-02-09
2024-02-13
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-3,257
$0.00
1
$20.42B
2024-02-09
2024-02-13
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
3,257
$0.00
1
$20.42B
2024-02-09
2024-02-13
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-2,272
$0.00
1
$20.42B
2024-02-09
2024-02-13
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
2,272
$0.00
1
$20.42B
2024-02-09
2024-02-13
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,212
$0.00
1
$20.42B
2024-02-09
2024-02-13
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-445
$241.00
-107K
1
$20.42B
2024-02-09
2024-02-13
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,212
$0.00
1
$20.42B
2024-02-09
2024-02-13
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-938
$241.00
-226K
1
$20.42B
2024-02-08
2024-02-09
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Common Stock
2,190
$0.00
1
$20.42B
2024-02-08
2024-02-09
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
1,635
$0.00
1
$20.42B
2024-02-08
2024-02-09
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-2,043
$0.00
1
$20.42B
2024-02-08
2024-02-09
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
2,043
$0.00
1
$20.42B
2024-02-08
2024-02-09
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-788
$0.00
1
$20.42B
2024-02-08
2024-02-09
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
788
$0.00
1
$20.42B
2024-02-08
2024-02-09
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-2,335
$0.00
1
$20.42B
2024-02-08
2024-02-09
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
2,335
$0.00
1
$20.42B
2024-02-08
2024-02-09
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-2,101
$0.00
1
$20.42B
2024-02-08
2024-02-09
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
2,101
$0.00
1
$20.42B
2024-02-08
2024-02-09
ALEXANDER SUSAN
EVP Chief Legal Officer
F - Tax
Common Stock
-655
$240.00
-157K
1
$20.42B
2024-02-08
2024-02-09
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-498
$240.00
-120K
1
$20.42B
2024-02-08
2024-02-09
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-621
$240.00
-149K
1
$20.42B
2024-02-08
2024-02-09
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-253
$240.00
-60,720
1
$20.42B
2024-02-08
2024-02-09
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-765
$240.00
-184K
1
$20.42B
2024-02-08
2024-02-09
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-638
$240.00
-153K
1
$20.42B
2024-02-08
2024-02-09
ALEXANDER SUSAN
EVP Chief Legal Officer
M - Exercise
Restricted Stock Unit
-2,190
$0.00
1
$20.42B
2024-02-08
2024-02-09
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-1,635
$0.00
1
$20.42B
2024-02-07
2024-02-09
SINGHAL PRIYA
Head of Development
A - Grant
Restricted Stock Unit
6,650
$0.00
1
$20.42B
2024-02-07
2024-02-09
IZZAR RACHID
Head of Global Product Strat.
A - Grant
Restricted Stock Unit
5,405
$0.00
1
$20.42B
2024-02-07
2024-02-09
ALEXANDER SUSAN
EVP Chief Legal Officer
A - Grant
Restricted Stock Unit
5,820
$0.00
1
$20.42B
2024-02-07
2024-02-09
GREGORY GINGER
EVP, Human Resources
A - Grant
Restricted Stock Unit
5,405
$0.00
1
$20.42B
2024-02-07
2024-02-09
GROGAN JANE
Head of Research
A - Grant
Restricted Stock Unit
4,155
$0.00
1
$20.42B
2024-02-07
2024-02-09
KEENEY ADAM
Head of Corporate Development
A - Grant
Restricted Stock Unit
5,405
$0.00
1
$20.42B
2024-02-07
2024-02-09
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
2,110
$0.00
1
$20.42B
2024-02-07
2024-02-09
MCDONNELL MICHAEL
EVP, Chief Financial Officer
A - Grant
Restricted Stock Unit
6,650
$0.00
1
$20.42B
2024-02-07
2024-02-09
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Restricted Stock Unit
5,820
$0.00
1
$20.42B
2024-02-07
2024-02-09
VIEHBACHER CHRISTOPHER
President and CEO
A - Grant
Restricted Stock Unit
27,025
$0.00
1
$20.42B
2024-02-02
2024-02-05
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-634
$246.00
-156K
1
$20.42B
2024-02-01
2024-02-05
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-561
$248.00
-139K
1
$20.42B
2024-02-01
2024-02-05
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,828
$0.00
1
$20.42B
2024-02-01
2024-02-05
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,828
$0.00
1
$20.42B
2024-01-29
2024-01-31
ALEXANDER SUSAN
EVP Chief Legal Officer
A - Grant
Performance Stock Unit
3,423
$0.00
1
$20.42B
2024-01-29
2024-01-31
GREGORY GINGER
EVP, Human Resources
A - Grant
Performance Stock Unit
3,197
$0.00
1
$20.42B
2024-01-29
2024-01-31
IZZAR RACHID
Head of Global Product Strat.
A - Grant
Performance Stock Unit
1,370
$0.00
1
$20.42B
2024-01-29
2024-01-31
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Performance Stock Unit
914
$0.00
1
$20.42B
2024-01-29
2024-01-31
MCDONNELL MICHAEL
EVP, Chief Financial Officer
A - Grant
Performance Stock Unit
4,568
$0.00
1
$20.42B
2024-01-29
2024-01-31
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Performance Stock Unit
856
$0.00
1
$20.42B
2024-01-29
2024-01-31
SINGHAL PRIYA
Head of Development
A - Grant
Performance Stock Unit
819
$0.00
1
$20.42B
2023-12-11
2023-12-12
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-110
$248.00
-27,280
1
$20.42B
2023-12-08
2023-12-12
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-426
$0.00
1
$20.42B
2023-12-08
2023-12-12
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-170
$239.00
-40,630
1
$20.42B
2023-12-08
2023-12-12
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-206
$239.00
-49,234
1
$20.42B
2023-12-08
2023-12-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-351
$0.00
1
$20.42B
2023-12-08
2023-12-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
351
$0.00
1
$20.42B
2023-12-08
2023-12-12
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
426
$0.00
1
$20.42B
2023-11-01
2023-11-03
GROGAN JANE
Head of Research
A - Grant
Restricted Stock Unit
2,085
$0.00
1
$20.42B
2023-09-05
2023-09-06
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-431
$269.00
-116K
1
$20.42B
2023-09-01
2023-09-06
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-807
$267.00
-215K
1
$20.42B
2023-09-01
2023-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-2,763
$0.00
1
$20.42B
2023-09-01
2023-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-5,285
$0.00
2
$20.42B
2023-09-01
2023-09-06
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,668
$0.00
1
$20.42B
2023-09-01
2023-09-06
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,668
$0.00
1
$20.42B
2023-09-01
2023-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
5,285
$0.00
2
$20.42B
2023-09-01
2023-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-2,704
$267.00
-722K
2
$20.42B
2023-07-03
2023-07-05
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-81
$283.00
-22,923
1
$20.42B
2023-06-30
2023-07-05
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
252
$0.00
1
$20.42B
2023-06-30
2023-07-05
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-244
$285.00
-69,540
1
$20.42B
2023-06-30
2023-07-05
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-122
$285.00
-34,770
1
$20.42B
2023-06-30
2023-07-05
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-153
$285.00
-43,605
1
$20.42B
2023-06-30
2023-07-05
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-504
$0.00
1
$20.42B
2023-06-30
2023-07-05
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
504
$0.00
1
$20.42B
2023-06-30
2023-07-05
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-252
$0.00
1
$20.42B
2023-06-30
2023-07-05
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-315
$0.00
1
$20.42B
2023-06-30
2023-07-05
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
315
$0.00
1
$20.42B
2023-06-26
2023-06-28
ROWINSKY ERIC
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-06-26
2023-06-28
SHERWIN STEPHEN
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-06-26
2023-06-28
DORSA CAROLINE
A - Grant
Common Stock
1,580
$0.00
1
$20.42B
2023-06-26
2023-06-28
FREIRE MARIA
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-06-26
2023-06-28
HAWKINS WILLIAM
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-06-26
2023-06-28
LANGER SUSAN
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-06-26
2023-06-28
MANTAS JESUS
A - Grant
Common Stock
960
$0.00
1
$20.42B
2023-05-01
2023-05-02
KEENEY ADAM
Head of Corporate Development
A - Grant
Restricted Stock Unit
2,815
$0.00
1
$20.42B
2023-04-28
2023-05-02
GREGORY GINGER
EVP, Human Resources
S - Sale
Common Stock
-2,681
$300.00
-804K
1
$20.42B
2023-04-04
2023-04-06
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-91
$277.00
-25,207
1
$20.42B
2023-03-31
2023-04-04
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-116
$278.00
-32,248
1
$20.42B
2023-03-31
2023-04-04
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-239
$0.00
1
$20.42B
2023-03-31
2023-04-04
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
239
$0.00
1
$20.42B
2023-03-28
2023-03-30
SINGHAL PRIYA
Head of Development
S - Sale
Common Stock
-568
$270.00
-153K
1
$20.42B
2023-03-02
2023-03-06
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-687
$269.00
-185K
2
$20.42B
2023-03-02
2023-03-06
SINGHAL PRIYA
Head of Development
J - Other
Restricted Stock Unit
-341
$0.00
1
$20.42B
2023-03-02
2023-03-06
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-297
$0.00
1
$20.42B
2023-03-02
2023-03-06
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
297
$0.00
1
$20.42B
2023-02-17
2023-02-22
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-2,271
$0.00
1
$20.42B
2023-02-17
2023-02-22
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-426
$0.00
1
$20.42B
2023-02-17
2023-02-22
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
F - Tax
Common Stock
-929
$278.00
-258K
1
$20.42B
2023-02-17
2023-02-22
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-867
$278.00
-241K
1
$20.42B
2023-02-17
2023-02-22
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-371
$278.00
-103K
1
$20.42B
2023-02-17
2023-02-22
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-238
$278.00
-66,164
1
$20.42B
2023-02-17
2023-02-22
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,310
$278.00
-364K
1
$20.42B
2023-02-17
2023-02-22
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-233
$278.00
-64,774
1
$20.42B
2023-02-17
2023-02-22
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-151
$278.00
-41,978
1
$20.42B
2023-02-17
2023-02-22
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
J - Other
Restricted Stock Unit
-1,702
$0.00
1
$20.42B
2023-02-17
2023-02-22
GREGORY GINGER
EVP, Human Resources
J - Other
Restricted Stock Unit
-1,590
$0.00
1
$20.42B
2023-02-17
2023-02-22
IZZAR RACHID
Head of Global Product Strat.
J - Other
Restricted Stock Unit
-681
$0.00
1
$20.42B
2023-02-17
2023-02-22
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-454
$0.00
1
$20.42B
2023-02-17
2023-02-22
SINGHAL PRIYA
Head of Development
J - Other
Restricted Stock Unit
-408
$0.00
1
$20.42B
2023-02-17
2023-02-22
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Restricted Stock Unit
-1,920
$0.00
1
$20.42B
2023-02-17
2023-02-22
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Common Stock
1,920
$0.00
1
$20.42B
2023-02-17
2023-02-22
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-1,792
$0.00
1
$20.42B
2023-02-17
2023-02-22
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
1,792
$0.00
1
$20.42B
2023-02-17
2023-02-22
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-767
$0.00
1
$20.42B
2023-02-17
2023-02-22
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
767
$0.00
1
$20.42B
2023-02-17
2023-02-22
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-512
$0.00
1
$20.42B
2023-02-17
2023-02-22
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
512
$0.00
1
$20.42B
2023-02-17
2023-02-22
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-2,561
$0.00
1
$20.42B
2023-02-17
2023-02-22
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
2,561
$0.00
1
$20.42B
2023-02-17
2023-02-22
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-480
$0.00
1
$20.42B
2023-02-17
2023-02-22
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
480
$0.00
1
$20.42B
2023-02-17
2023-02-22
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-460
$0.00
1
$20.42B
2023-02-17
2023-02-22
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
460
$0.00
1
$20.42B
2023-02-10
2023-02-14
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-416
$0.00
1
$20.42B
2023-02-10
2023-02-14
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
F - Tax
Common Stock
-4,202
$286.00
-1.20M
3
$20.42B
2023-02-10
2023-02-14
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-3,306
$286.00
-946K
3
$20.42B
2023-02-10
2023-02-14
IZZAR RACHID
Head of Global Product Strat.
F - Tax
Common Stock
-1,324
$286.00
-379K
3
$20.42B
2023-02-10
2023-02-14
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-590
$286.00
-169K
3
$20.42B
2023-02-10
2023-02-14
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-1,105
$286.00
-316K
1
$20.42B
2023-02-10
2023-02-14
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-1,387
$286.00
-397K
3
$20.42B
2023-02-10
2023-02-14
SINGHAL PRIYA
Head of Development
F - Tax
Common Stock
-372
$286.00
-106K
1
$20.42B
2023-02-10
2023-02-14
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
J - Other
Restricted Stock Unit
-1,770
$0.00
1
$20.42B
2023-02-10
2023-02-14
GREGORY GINGER
EVP, Human Resources
J - Other
Restricted Stock Unit
-1,384
$0.00
1
$20.42B
2023-02-10
2023-02-14
IZZAR RACHID
Head of Global Product Strat.
J - Other
Restricted Stock Unit
-553
$0.00
1
$20.42B
2023-02-10
2023-02-14
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-278
$0.00
1
$20.42B
2023-02-10
2023-02-14
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Restricted Stock Unit
-4,023
$0.00
2
$20.42B
2023-02-10
2023-02-14
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Common Stock
4,023
$0.00
2
$20.42B
2023-02-10
2023-02-14
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-3,290
$0.00
2
$20.42B
2023-02-10
2023-02-14
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
3,290
$0.00
2
$20.42B
2023-02-10
2023-02-14
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Restricted Stock Unit
-1,968
$0.00
2
$20.42B
2023-02-10
2023-02-14
IZZAR RACHID
Head of Global Product Strat.
M - Exercise
Common Stock
1,968
$0.00
2
$20.42B
2023-02-10
2023-02-14
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-1,061
$0.00
2
$20.42B
2023-02-10
2023-02-14
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
1,061
$0.00
2
$20.42B
2023-02-10
2023-02-14
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-3,256
$0.00
1
$20.42B
2023-02-10
2023-02-14
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
3,256
$0.00
1
$20.42B
2023-02-10
2023-02-14
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-2,611
$0.00
2
$20.42B
2023-02-10
2023-02-14
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
2,611
$0.00
2
$20.42B
2023-02-10
2023-02-14
SINGHAL PRIYA
Head of Development
M - Exercise
Restricted Stock Unit
-1,211
$0.00
1
$20.42B
2023-02-10
2023-02-14
SINGHAL PRIYA
Head of Development
M - Exercise
Common Stock
1,211
$0.00
1
$20.42B
2023-02-08
2023-02-10
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Restricted Stock Unit
6,305
$0.00
1
$20.42B
2023-02-08
2023-02-10
MCDONNELL MICHAEL
EVP, Chief Financial Officer
A - Grant
Restricted Stock Unit
7,005
$0.00
1
$20.42B
2023-02-08
2023-02-10
IZZAR RACHID
Head of Global Product Strat.
A - Grant
Restricted Stock Unit
6,130
$0.00
1
$20.42B
2023-02-08
2023-02-10
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
2,365
$0.00
1
$20.42B
2023-02-08
2023-02-10
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
A - Grant
Restricted Stock Unit
6,570
$0.00
1
$20.42B
2023-02-08
2023-02-10
GREGORY GINGER
EVP, Human Resources
A - Grant
Restricted Stock Unit
4,905
$0.00
1
$20.42B
2023-02-01
2023-02-03
SINGHAL PRIYA
Head of Development
A - Grant
Restricted Stock Unit
5,485
$0.00
1
$20.42B
2023-01-25
2023-01-27
SINGHAL PRIYA
Head of Development
A - Grant
Common Stock
1,123
$0.00
1
$20.42B
2023-01-25
2023-01-27
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
A - Grant
Common Stock
5,703
$0.00
1
$20.42B
2023-01-25
2023-01-27
GREGORY GINGER
EVP, Human Resources
A - Grant
Common Stock
4,452
$0.00
1
$20.42B
2023-01-25
2023-01-27
IZZAR RACHID
Head of Alzheimer's Disease
A - Grant
Common Stock
1,783
$0.00
1
$20.42B
2023-01-25
2023-01-27
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Common Stock
887
$0.00
1
$20.42B
2023-01-25
2023-01-27
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Common Stock
1,340
$0.00
1
$20.42B
2022-11-15
2023-01-27
SHERWIN STEPHEN
G - Gift
Common Stock
-695
$0.00
1
$20.42B
2022-06-07
2023-01-27
POSNER BRIAN
G - Gift
Common Stock
-150
$0.00
1
$20.42B
2022-12-08
2022-12-12
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-156
$289.00
-45,084
1
$20.42B
2022-12-08
2022-12-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-350
$0.00
1
$20.42B
2022-12-08
2022-12-12
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
350
$0.00
1
$20.42B
2022-11-14
2022-12-12
GREGORY GINGER
EVP, Human Resources
S - Sale
Common Stock
-5,610
$300.00
-1.68M
1
$20.42B
2022-12-02
2022-12-06
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-131
$0.00
1
$20.42B
2022-12-02
2022-12-06
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
131
$0.00
1
$20.42B
2022-12-02
2022-12-06
IZZAR RACHID
Head of Alzheimer's Disease
F - Tax
Common Stock
-759
$299.00
-227K
2
$20.42B
2022-12-02
2022-12-06
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-39
$299.00
-11,661
1
$20.42B
2022-12-02
2022-12-06
IZZAR RACHID
Head of Alzheimer's Disease
J - Other
Restricted Stock Unit
-433
$0.00
1
$20.42B
2022-12-02
2022-12-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Restricted Stock Unit
-1,710
$0.00
2
$20.42B
2022-12-02
2022-12-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Common Stock
1,710
$0.00
2
$20.42B
2022-12-01
2022-12-05
VIEHBACHER CHRISTOPHER
President and CEO
A - Grant
Stock Option
80,522
$0.00
1
$20.42B
2022-12-01
2022-12-05
VIEHBACHER CHRISTOPHER
President and CEO
A - Grant
Performance Stock Unit
45,998
$0.00
1
$20.42B
2022-12-01
2022-12-05
VIEHBACHER CHRISTOPHER
President and CEO
A - Grant
Restricted Stock Unit
7,040
$0.00
1
$20.42B
2022-10-27
2022-10-28
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
S - Sale
Common Stock
-5,532
$281.00
-1.55M
1
$20.42B
2022-09-01
2022-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-2,428
$200.00
-486K
2
$20.42B
2022-09-01
2022-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-3,298
$0.00
1
$20.42B
2022-09-01
2022-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-4,746
$0.00
2
$20.42B
2022-09-01
2022-09-06
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
4,746
$0.00
2
$20.42B
2022-08-01
2022-08-03
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-319
$209.00
-66,671
2
$20.42B
2022-08-01
2022-08-03
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-299
$0.00
1
$20.42B
2022-08-01
2022-08-03
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-1,080
$0.00
2
$20.42B
2022-08-01
2022-08-03
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
1,080
$0.00
2
$20.42B
2022-07-01
2022-07-06
IZZAR RACHID
Head of Alzheimer's Disease
F - Tax
Common Stock
-148
$211.00
-31,228
1
$20.42B
2022-07-01
2022-07-06
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-74
$211.00
-15,614
1
$20.42B
2022-07-01
2022-07-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Restricted Stock Unit
-504
$0.00
1
$20.42B
2022-07-01
2022-07-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Common Stock
504
$0.00
1
$20.42B
2022-07-01
2022-07-06
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-252
$0.00
1
$20.42B
2022-07-01
2022-07-06
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
252
$0.00
1
$20.42B
2022-06-15
2022-06-17
DENNER ALEXANDER
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
DORSA CAROLINE
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
FREIRE MARIA
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
HAWKINS WILLIAM
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
JONES WILLIAM /CA/
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
MANTAS JESUS
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
MULLIGAN RICHARD
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
PAPADOPOULOS STELIOS
A - Grant
Common Stock
2,255
$0.00
1
$20.42B
2022-06-15
2022-06-17
ROWINSKY ERIC
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-06-15
2022-06-17
SHERWIN STEPHEN
A - Grant
Common Stock
1,370
$0.00
1
$20.42B
2022-04-01
2022-04-05
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-84
$211.00
-17,724
1
$20.42B
2022-04-01
2022-04-05
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-239
1
$20.42B
2022-04-01
2022-04-05
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
239
1
$20.42B
2022-02-18
2022-02-23
VOUNATSOS MICHEL
Chief Executive Officer
J - Other
Restricted Stock Unit
-8,909
$0.00
1
$20.42B
2022-02-18
2022-02-23
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-977
$210.00
-205K
1
$20.42B
2022-02-18
2022-02-23
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-110
$210.00
-23,100
1
$20.42B
2022-02-18
2022-02-23
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-117
$210.00
-24,570
1
$20.42B
2022-02-18
2022-02-23
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
F - Tax
Common Stock
-659
$210.00
-138K
1
$20.42B
2022-02-18
2022-02-23
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-616
$210.00
-129K
1
$20.42B
2022-02-18
2022-02-23
GUINDO CHIRFI
Head of Glob Prod Strat & Com
F - Tax
Common Stock
-879
$210.00
-185K
1
$20.42B
2022-02-18
2022-02-23
IZZAR RACHID
Head of Alzheimer's Disease
F - Tax
Common Stock
-175
$210.00
-36,750
1
$20.42B
2022-02-18
2022-02-23
VOUNATSOS MICHEL
Chief Executive Officer
F - Tax
Common Stock
-2,746
$210.00
-577K
1
$20.42B
2022-02-18
2022-02-23
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
J - Other
Restricted Stock Unit
-2,137
$0.00
1
$20.42B
2022-02-18
2022-02-23
GREGORY GINGER
EVP, Human Resources
J - Other
Restricted Stock Unit
-1,995
$0.00
1
$20.42B
2022-02-18
2022-02-23
GUINDO CHIRFI
Head of Glob Prod Strat & Com
J - Other
Restricted Stock Unit
-2,851
$0.00
1
$20.42B
2022-02-18
2022-02-23
IZZAR RACHID
Head of Alzheimer's Disease
J - Other
Restricted Stock Unit
-854
$0.00
1
$20.42B
2022-02-18
2022-02-23
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-570
$0.00
1
$20.42B
2022-02-18
2022-02-23
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-2,851
$0.00
1
$20.42B
2022-02-18
2022-02-23
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-535
$0.00
1
$20.42B
2022-02-18
2022-02-23
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Restricted Stock Unit
-1,485
$0.00
1
$20.42B
2022-02-18
2022-02-23
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Common Stock
1,485
$0.00
1
$20.42B
2022-02-18
2022-02-23
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-1,387
$0.00
1
$20.42B
2022-02-18
2022-02-23
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
1,387
$0.00
1
$20.42B
2022-02-18
2022-02-23
GUINDO CHIRFI
Head of Glob Prod Strat & Com
M - Exercise
Restricted Stock Unit
-1,981
$0.00
1
$20.42B
2022-02-18
2022-02-23
GUINDO CHIRFI
Head of Glob Prod Strat & Com
M - Exercise
Common Stock
1,981
$0.00
1
$20.42B
2022-02-18
2022-02-23
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Restricted Stock Unit
-594
$0.00
1
$20.42B
2022-02-18
2022-02-23
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Common Stock
594
$0.00
1
$20.42B
2022-02-18
2022-02-23
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-396
$0.00
1
$20.42B
2022-02-18
2022-02-23
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
396
$0.00
1
$20.42B
2022-02-18
2022-02-23
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-1,981
$0.00
1
$20.42B
2022-02-18
2022-02-23
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
1,981
$0.00
1
$20.42B
2022-02-18
2022-02-23
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-371
$0.00
1
$20.42B
2022-02-18
2022-02-23
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
371
$0.00
1
$20.42B
2022-02-18
2022-02-23
VOUNATSOS MICHEL
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-6,191
$0.00
1
$20.42B
2022-02-18
2022-02-23
VOUNATSOS MICHEL
Chief Executive Officer
M - Exercise
Common Stock
6,191
$0.00
1
$20.42B
2022-02-12
2022-02-15
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
F - Tax
Common Stock
-2,056
$215.00
-442K
3
$20.42B
2022-02-12
2022-02-15
GREGORY GINGER
EVP, Human Resources
F - Tax
Common Stock
-1,252
$215.00
-269K
3
$20.42B
2022-02-12
2022-02-15
GUINDO CHIRFI
Head of Glob Prod Strat & Com
F - Tax
Common Stock
-2,342
$215.00
-504K
3
$20.42B
2022-02-12
2022-02-15
IZZAR RACHID
Head of Alzheimer's Disease
F - Tax
Common Stock
-122
$215.00
-26,230
1
$20.42B
2022-02-12
2022-02-15
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-171
$215.00
-36,765
3
$20.42B
2022-02-12
2022-02-15
MURPHY NICOLE
Head of Pharm Ops and Tech
F - Tax
Common Stock
-92
$215.00
-19,780
1
$20.42B
2022-02-12
2022-02-15
VOUNATSOS MICHEL
Chief Executive Officer
F - Tax
Common Stock
-8,566
$215.00
-1.84M
3
$20.42B
2022-02-12
2022-02-15
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
J - Other
Restricted Stock Unit
-4,280
$0.00
2
$20.42B
2022-02-12
2022-02-15
GREGORY GINGER
EVP, Human Resources
J - Other
Restricted Stock Unit
-3,138
$0.00
2
$20.42B
2022-02-12
2022-02-15
GUINDO CHIRFI
Head of Glob Prod Strat & Com
J - Other
Restricted Stock Unit
-4,875
$0.00
2
$20.42B
2022-02-12
2022-02-15
IZZAR RACHID
Head of Alzheimer's Disease
J - Other
Restricted Stock Unit
-651
$0.00
1
$20.42B
2022-02-12
2022-02-15
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-515
$0.00
2
$20.42B
2022-02-12
2022-02-15
MURPHY NICOLE
Head of Pharm Ops and Tech
J - Other
Restricted Stock Unit
-489
$0.00
1
$20.42B
2022-02-12
2022-02-15
VOUNATSOS MICHEL
Chief Executive Officer
J - Other
Restricted Stock Unit
-16,368
$0.00
2
$20.42B
2022-02-12
2022-02-15
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Restricted Stock Unit
-2,280
$0.00
2
$20.42B
2022-02-12
2022-02-15
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
M - Exercise
Common Stock
2,280
$0.00
2
$20.42B
2022-02-12
2022-02-15
GREGORY GINGER
EVP, Human Resources
M - Exercise
Restricted Stock Unit
-1,672
$0.00
2
$20.42B
2022-02-12
2022-02-15
GREGORY GINGER
EVP, Human Resources
M - Exercise
Common Stock
1,672
$0.00
2
$20.42B
2022-02-12
2022-02-15
GUINDO CHIRFI
Head of Glob Prod Strat & Com
M - Exercise
Restricted Stock Unit
-2,597
$0.00
2
$20.42B
2022-02-12
2022-02-15
GUINDO CHIRFI
Head of Glob Prod Strat & Com
M - Exercise
Common Stock
2,597
$0.00
2
$20.42B
2022-02-12
2022-02-15
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Restricted Stock Unit
-351
$0.00
1
$20.42B
2022-02-12
2022-02-15
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Common Stock
351
$0.00
1
$20.42B
2022-02-12
2022-02-15
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-275
$0.00
2
$20.42B
2022-02-12
2022-02-15
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
275
$0.00
2
$20.42B
2022-02-12
2022-02-15
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Restricted Stock Unit
-263
$0.00
1
$20.42B
2022-02-12
2022-02-15
MURPHY NICOLE
Head of Pharm Ops and Tech
M - Exercise
Common Stock
263
$0.00
1
$20.42B
2022-02-12
2022-02-15
VOUNATSOS MICHEL
Chief Executive Officer
M - Exercise
Restricted Stock Unit
-8,716
$0.00
2
$20.42B
2022-02-12
2022-02-15
VOUNATSOS MICHEL
Chief Executive Officer
M - Exercise
Common Stock
8,716
$0.00
2
$20.42B
2022-02-10
2022-02-14
MCDONNELL MICHAEL
EVP, Chief Financial Officer
A - Grant
Restricted Stock Unit
9,770
$0.00
1
$20.42B
2022-02-10
2022-02-14
MURPHY NICOLE
Head of Pharm Ops and Tech
A - Grant
Restricted Stock Unit
6,815
$0.00
1
$20.42B
2022-02-10
2022-02-14
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
A - Grant
Restricted Stock Unit
7,725
$0.00
1
$20.42B
2022-02-10
2022-02-14
GREGORY GINGER
EVP, Human Resources
A - Grant
Restricted Stock Unit
6,475
$0.00
1
$20.42B
2022-02-10
2022-02-14
GUINDO CHIRFI
Head of Glob Prod Strat & Com
A - Grant
Restricted Stock Unit
9,090
$0.00
1
$20.42B
2022-02-10
2022-02-14
IZZAR RACHID
Head of Alzheimer's Disease
A - Grant
Restricted Stock Unit
4,545
$0.00
1
$20.42B
2022-02-10
2022-02-14
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
2,500
$0.00
1
$20.42B
2022-02-10
2022-02-14
VOUNATSOS MICHEL
Chief Executive Officer
A - Grant
Restricted Stock Unit
28,405
$0.00
1
$20.42B
2022-01-19
2022-01-21
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
A - Grant
Common Stock
2,825
$0.00
1
$20.42B
2022-01-19
2022-01-21
GALDES ALPHONSE
EVP Pharmaceutical Oper & Tech
A - Grant
Common Stock
658
$0.00
1
$20.42B
2022-01-19
2022-01-21
GREGORY GINGER
EVP, Human Resources
A - Grant
Common Stock
1,941
$0.00
1
$20.42B
2022-01-19
2022-01-21
GUINDO CHIRFI
Head of Glob Prod Strat & Com
A - Grant
Common Stock
3,088
$0.00
1
$20.42B
2022-01-19
2022-01-21
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Common Stock
244
$0.00
1
$20.42B
2022-01-19
2022-01-21
VOUNATSOS MICHEL
Chief Executive Officer
A - Grant
Common Stock
10,594
$0.00
1
$20.42B
2021-08-09
2022-01-21
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
G - Gift
Common Stock
-523
$0.00
1
$20.42B
2021-12-08
2021-12-10
KRAMER ROBIN
Chief Accounting Officer
A - Grant
Restricted Stock Unit
1,052
$0.00
1
$20.42B
2021-12-03
2021-12-07
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-100
$224.00
-22,400
2
$20.42B
2021-12-03
2021-12-07
KRAMER ROBIN
Chief Accounting Officer
J - Other
Restricted Stock Unit
-104
$0.00
1
$20.42B
2021-12-03
2021-12-07
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-339
$0.00
2
$20.42B
2021-12-03
2021-12-07
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
339
$224.00
75,936
2
$20.42B
2021-12-02
2021-12-06
IZZAR RACHID
Head of Alzheimer's Disease
F - Tax
Common Stock
-165
$229.00
-37,785
1
$20.42B
2021-12-02
2021-12-06
IZZAR RACHID
Head of Alzheimer's Disease
J - Other
Restricted Stock Unit
-484
$0.00
1
$20.42B
2021-12-02
2021-12-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Restricted Stock Unit
-372
$0.00
1
$20.42B
2021-12-02
2021-12-06
IZZAR RACHID
Head of Alzheimer's Disease
M - Exercise
Common Stock
372
$229.00
85,188
1
$20.42B
2021-09-01
2021-09-03
MCDONNELL MICHAEL
EVP, Chief Financial Officer
F - Tax
Common Stock
-2,582
$338.00
-873K
2
$20.42B
2021-09-01
2021-09-03
MCDONNELL MICHAEL
EVP, Chief Financial Officer
J - Other
Restricted Stock Unit
-2,038
$0.00
1
$20.42B
2021-09-01
2021-09-03
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Restricted Stock Unit
-6,005
$0.00
2
$20.42B
2021-09-01
2021-09-03
MCDONNELL MICHAEL
EVP, Chief Financial Officer
M - Exercise
Common Stock
6,005
$338.00
2.03M
2
$20.42B
2021-07-01
2021-07-02
HAWKINS WILLIAM
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
ROWINSKY ERIC
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
SHERWIN STEPHEN
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
KRAMER ROBIN
Chief Accounting Officer
F - Tax
Common Stock
-74
$349.00
-25,826
1
$20.42B
2021-07-01
2021-07-02
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Restricted Stock Unit
-251
$0.00
1
$20.42B
2021-07-01
2021-07-02
DENNER ALEXANDER
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
DORSA CAROLINE
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
FREIRE MARIA
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
JONES WILLIAM /CA/
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
LEAMING NANCY
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
MANTAS JESUS
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
MULLIGAN RICHARD
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
PAPADOPOULOS STELIOS
A - Grant
Common Stock
1,275
$0.00
1
$20.42B
2021-07-01
2021-07-02
POSNER BRIAN
A - Grant
Common Stock
775
$0.00
1
$20.42B
2021-07-01
2021-07-02
KRAMER ROBIN
Chief Accounting Officer
M - Exercise
Common Stock
251
$349.00
87,599
1
$20.42B
2021-06-07
2021-06-09
GUINDO CHIRFI
Head of Glob Prod Strat & Com
S - Sale
Common Stock
-3,087
$440.00
-1.36M
1
$20.42B
2021-06-07
2021-06-09
SANDROCK ALFRED
Head of Research & Development
S - Sale
Common Stock
-7,672
$440.00
-3.38M
1
$20.42B
2021-06-04
2021-06-07
POSNER BRIAN
S - Sale
Common Stock
-360
$274.00
-98,640
1
$20.42B
2021-02-18
2021-02-22
ALEXANDER SUSAN
EVP Chief Legal Off & Corp Sec
A - Grant
Restricted Stock Unit
10,870
$0.00
1
$20.42B
2021-02-18
2021-02-22
GALDES ALPHONSE
EVP Pharmaceutical Oper & Tech
A - Grant
Restricted Stock Unit
10,870
$0.00
1
$20.42B
2021-02-18
2021-02-22
GREGORY GINGER
EVP, Human Resources
A - Grant
Restricted Stock Unit
10,150
$0.00
1
$20.42B